Novel Therapy 4
NOVEL THERAPY Clinical trial leads to new melanoma drug Groundbreaking new drug approved by the FDA. Read Story
Day: November 3, 2023
Novel Therapy 3
NOVEL THERAPY Dramatic response to clinical trial for stage 4 lung cancer Patient remains cancer-free more than three years after treatment. Read Story
Novel Therapy 2
NOVEL THERAPY Researchers improve immunotherapy technique New diagnostics could increase precision of existing therapies. Read Story
Novel Therapy 1
NOVEL THERAPY Mask cancer drug reduces side-effects New immunotherapy would activate on contact with tumors. Read Story
Cyrus Tang Foundation Award funds partnership to improve community-based healthcare in China
Communities around the globe face the challenge of delivering high-quality healthcare while managing skyrocketing healthcare expenses. The Cyrus Tang Foundation recently awarded a three-year, $900,000 grant to the University of
Adaptive Oncology 2
ADAPTIVE ONCOLOGY AI trained to predict immunotherapy outcomes Researchers aim to tailor treatments for lung cancer patients. Read Story
Adaptive Oncology 3
ADAPTIVE ONCOLOGY Clinical trial targets chemotherapy-resistant cancer Ovarian cancer patient sees rapid improvement on new drug. Read Story
Adaptive Oncology 1
ADAPTIVE ONCOLOGY AI software aids breast cancer diagnosis Software wins Best Inventions award for 2019. Read Story